We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi and GlaxoSmithKline Reenter COVID-19 Vaccine Race With Phase 2 Results
Sanofi and GlaxoSmithKline Reenter COVID-19 Vaccine Race With Phase 2 Results
Sanofi and GlaxoSmithKline (GSK) have reemerged as COVID-19 vaccine contenders after their reformulated candidate delivered a strong immune response across all age groups in a phase 2 study.